Skip to main content
. 2022 Jan 16;11(2):450. doi: 10.3390/jcm11020450

Table 1.

Comparison of preoperative recipient clinical factors between the non-AKI and AKI groups.

Group Non-AKI AKI p
n 472 145
Preoperative recipient factor
Age (years) 54 (48–59) 52 (48–58) 0.297
Sex (male) 324 (68.6%) 108 (74.5%) 0.180
Body mass index (kg/m2) 24 (22–26) 24 (22–28) 0.118
Etiology
Alcohol 84 (17.8%) 37 (25.5%) 0.268
Hepatitis A 18 (3.8%) 8 (5.5%)
Hepatitis B 270 (57.2%) 79 (54.5%)
Hepatitis C 37 (7.8%) 8 (5.5%)
Autoimmune 23 (4.9%) 3 (2.1%)
Drug & Toxin 10 (2.1%) 2 (1.4%)
Cryptogenic 30 (6.4%) 8 (5.5%)
Comorbidity
Diabetes mellitus 114 (24.2%) 48 (33.1%) 0.032
Hypertension 95 (20.1%) 30 (20.7%) 0.883
MELD score (point) 12 (6–23) 17 (10–25) 0.007
Hepatic decompensation
Encephalopathy
(West-Haven criteria I or II)
38 (8.1%) 17 (11.7%) 0.175
Varix 111 (23.5%) 39 (26.9%) 0.407
Ascites 209 (44.3%) 83 (57.2%) 0.006
Cardiac function
Ejection fraction (%) 64 (62–67) 64 (62–67) 0.303
Diastolic dysfunction 193 (40.9%) 65 (44.8%) 0.4
Renal function
eGFR (mL/min/1.73 m2) 90.5 (77.0–114.1) 87.4 (74.1–117.2) 0.832
Laboratory variables
Hemoglobin (g/dL) 10 (8.4–12) 9.4 (8.1–10.8) 0.008
WBC count (×109/L) 4.3 (2.8–6.8) 4.6 (3.1–8) 0.249
Albumin (g/dL) 3.1 (2.7–3.6) 2.9 (2.6–3.3) 0.001
Platelet count (×109/L) 67.5 (47–110) 55 (39–77) <0.001
International normalized ratio 1.4 (1.2–2.1) 1.6 (1.3–2.1) 0.025
Activated partial thrombin
time (sec)
35.3 (28.5–51) 33.5 (29–46) 0.156
D-dimer (mg/L) 3 (0.8–6.5) 5.4 (2.5–9.8) <0.001
Sodium (mEq/L) 139 (135–142) 138 (135–141) 0.078
Potassium (mEq/L) 4 (3.7–4.3) 4 (3.6–4.3) 0.362
Calcium (mg/dL) 8.4 (8–8.8) 8.4 (7.9–8.8) 0.307
Glucose (mg/dL) 108 (91–139) 112 (96–142) 0.218
Creatinine (mg/dL) 0.9 (0.7–1.1) 0.9 (0.7–1.3) 0.589
Ammonia (μg/dL) 95 (65–148) 105 (68–160) 0.442

Abbreviations: AKI, acute kidney injury; eGFR, estimated glomerular filtration rate; MELD, Model for End-stage Liver Disease; WBC, white blood cell. NOTE: Values are medians (ranges) or numbers (percentages).